Theravance Biopharma (TBPH) Treasury Shares (2014 - 2026)

Theravance Biopharma (TBPH) has 13 years of Treasury Shares data on file, last reported at $2.4 million in Q1 2026.

• On a quarterly basis, Treasury Shares fell 47.41% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 47.41% decrease from a year earlier, with the FY2025 full-year figure at $3.2 million, down 19.04% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.4 million, down from $3.2 million in the prior quarter.
• Over the last five years, Treasury Shares for TBPH reached as high as $4.5 million in Q2 2024 and fell as low as $2.4 million in Q1 2026.
• Historically, Treasury Shares has averaged $3.8 million across 5 years, with a median of $4.0 million in 2023.
• Across the five-year window, Treasury Shares slumped 50.8% in 2022 and surged 45.84% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $4.1 million in 2022, then decreased by 2.78% to $4.0 million in 2023, then declined by 1.01% to $4.0 million in 2024, then retreated by 19.04% to $3.2 million in 2025, then retreated by 26.36% to $2.4 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $2.4 million in Q1 2026, $3.2 million in Q4 2025, and $3.7 million in Q3 2025.